SciBac

Best Antibiotic Resistant Disease Therapeutics Company - USA
Best Pseudomonas Aeruginosa Prevention Biotherapeutic 2022: Aeruguard (SCB-203)
Winners image
<p>SciBac creates rEvolutionary live biotherapeutics that treat antibiotic resistant disease, starting with lung infections, while fortifying the microbiome. We improve beneficial microorganisms using our novel platform technology that can quickly, naturally, and safely transfer useful genetic traits. The resulting microorganisms have all the best traits to target a specific disease through multiple modes of action and enhance the microbiome for faster recovery and reduced risk of reinfections. </p>